Results 151 to 160 of about 4,439,667 (350)
Human Engineering for the Design of Easily Controllable Machines
Sumiji FUJII, Masakazu IGUCHI
openalex +2 more sources
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Retracted: UAV Tilt Photography Control for Numerical Simulation of High and Steep Rock Slopes
Journal of Control Science and Engineering
doaj +1 more source
Synthetic biology and regulatory networks: where metabolic systems biology meets control engineering. [PDF]
He F, Murabito E, Westerhoff HV.
europepmc +1 more source
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho+11 more
wiley +1 more source
Journal of Control Science and Engineering
doaj +1 more source
Erratum for “Optimal Control of Civil Engineering Structures” [PDF]
Mohamed Abdel‐Rohman+2 more
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source